We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

137 hedge funds and large institutions have $506M invested in Albany Molecular Research Inc in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 47 increasing their positions, 49 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $394M → $506M (+$112M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 49

4% less funds holding

Funds holding: 142 → 137 (-5)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

98% less call options, than puts

Call options by funds: $1.41M | Put options by funds: $79.9M

Holders
137
Holders Change
-5
Holders Change %
-3.52%
% of All Funds
3.66%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
47
Reduced
49
Closed
16
Calls
$1.41M
Puts
$79.9M
Net Calls
-$78.5M
Net Calls Change
-$14.8M

Top Buyers

Rank Fund Capital Flow
1
ACM
American Capital Management
New York
+$20.3M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$6.72M
3
EA
Emerald Advisers
Pennsylvania
+$6.13M
4
JP Morgan Chase
JP Morgan Chase
New York
+$3.94M
5
PIP
Permian Investment Partners
Texas
+$3.56M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.1M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$3.03M
3
Morgan Stanley
Morgan Stanley
New York
-$2.19M
4
PI
Putnam Investments
Massachusetts
-$1.94M
5
FSA
Franklin Street Advisors
North Carolina
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$5.71M -$580K -39,149 -10%
Skandinaviska Enskilda Banken (SEB)
27
Skandinaviska Enskilda Banken (SEB)
Sweden
$5.11M +$240K +16,200 +6%
HVC
28
Healthcare Value Capital
New Jersey
$4.99M – – –
EA
29
Emerald Acquisition
Washington
$3.58M -$301K -20,328 -9%
BA
30
BlackRock Advisors
Delaware
$3.41M +$2.88M +194,401 +1,570%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$3.15M +$38.8K +2,622 +1%
Natixis Advisors
32
Natixis Advisors
Massachusetts
$3.09M +$233K +15,696 +9%
Deutsche Bank
33
Deutsche Bank
Germany
$3.06M +$291K +19,638 +12%
PTC
34
Philadelphia Trust Company
Pennsylvania
$2.94M -$58.9K -3,975 -2%
Principal Financial Group
35
Principal Financial Group
Iowa
$2.68M -$424K -28,631 -15%
Fisher Asset Management
36
Fisher Asset Management
Washington
$2.6M -$676K -45,656 -22%
SAMC
37
Shinko Asset Management Company
Japan
$2.6M -$676K -45,656 -22%
PI
38
Putnam Investments
Massachusetts
$2.44M -$1.94M -130,999 -47%
MAP
39
Moody Aldrich Partners
Massachusetts
$2.31M +$215K +14,520 +12%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$2.24M -$133K -9,000 -6%
MOACM
41
Mutual of America Capital Management
New York
$2.12M +$420K +28,345 +28%
CSC
42
Cove Street Capital
California
$1.98M – – –
BIM
43
BlackRock Investment Management
Delaware
$1.92M -$33K -2,228 -2%
AA
44
Ancora Advisors
Ohio
$1.89M – – –
Ameriprise
45
Ameriprise
Minnesota
$1.87M -$257K -17,360 -13%
Wells Fargo
46
Wells Fargo
California
$1.85M +$592K +39,975 +56%
WC
47
Walthausen & Co
New York
$1.8M +$1.62M +109,280 New
CS
48
Credit Suisse
Switzerland
$1.76M +$1.05M +70,976 +198%
Two Sigma Investments
49
Two Sigma Investments
New York
$1.62M +$1.02M +68,884 +236%
Bessemer Group
50
Bessemer Group
New Jersey
$1.53M +$25.2K +1,704 +2%
1
2
3 4 5

AMRI Hedge Fund Activity: Q3 2016 in Review

137 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2016, worth a combined $506M — up 28% from $394M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of AMRI and 11 opened new positions — a net loss of 5 holders — while 49 trimmed existing stakes and 47 added.

The largest buyer was American Capital Management, opening a new position worth an estimated $20.3M. The largest seller was Wellington Management Group, exiting entirely with an estimated $16.1M sold.

  • 137 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2016, down from 142 in Q2 2016.
  • Funds reported $506M of Albany Molecular Research Inc stock for Q3 2016, up 28% quarter-over-quarter.
  • 11 funds opened new Albany Molecular Research Inc positions in Q3 2016 and 16 closed out, a net change of -5 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2016 was American Capital Management, an estimated $20.3M added.
  • The largest Albany Molecular Research Inc seller in Q3 2016 was Wellington Management Group, an estimated $16.1M sold.

Based on aggregated 13F filings for Q3 2016.